Mesoporous silica/organosilica nanoparticles for cancer immunotherapy

Cancer is one of the fatal diseases in the history of humankind. In this regard, cancer immunotherapeutic strategies have revolutionized the traditional mode of cancer treatment. Silica based nano‐platforms have been extensively applied in nanomedicine including cancer immunotherapy. Mesoporous sili...

Full description

Saved in:
Bibliographic Details
Published inExploration (Beijing, China) Vol. 3; no. 3; pp. 20220086 - n/a
Main Authors Theivendran, Shevanuja, Lazarev, Sergei, Yu, Chengzhong
Format Journal Article
LanguageEnglish
Published China John Wiley & Sons, Inc 01.06.2023
Wiley
Subjects
Cancer
Cancer immunotherapy
Cancer therapies
Drug delivery systems
Hydrocarbons
Immunotherapy
Morphology
Nanoparticles
Nanotechnology
organosilica
Pore size
Side effects
Silica
Silicon dioxide
Surfactants
Synergism
Tumor microenvironment
cancer
organosilica
nanoparticles
silica
immunotherapy
Online AccessGet full text

Cover

Abstract Cancer is one of the fatal diseases in the history of humankind. In this regard, cancer immunotherapeutic strategies have revolutionized the traditional mode of cancer treatment. Silica based nano‐platforms have been extensively applied in nanomedicine including cancer immunotherapy. Mesoporous silica nanoparticles (MSN) and mesoporous organosilica nanoparticles (MON) are attractive candidates due to the ease in controlling the structural parameters as needed for the targeted immunotherapeutic applications. Especially, the MON provide an additional advantage of controlling the composition and modulating the biological functions to actively synergize with other immunotherapeutic strategies. In this review, the applications of MSN, MON, and metal‐doped MSN/MON in the field of cancer immunotherapy and tumor microenvironment regulation are comprehensively summarized by highlighting the structural and compositional attributes of the silica‐based nanoplatforms. Silica based nanoparticles have been extensively applied in nanomedicine including cancer immunotherapy. In this review, the applications of mesoporous silica nanoparticles (MSN), mesoporous organosilica nanoparticles (MON), and metal‐doped MSN/MON in the field of cancer immunotherapy and tumor microenvironment regulation are comprehensively summarized by highlighting the structural and compositional attributes of the silica‐based nanoplatforms.
AbstractList Cancer is one of the fatal diseases in the history of humankind. In this regard, cancer immunotherapeutic strategies have revolutionized the traditional mode of cancer treatment. Silica based nano-platforms have been extensively applied in nanomedicine including cancer immunotherapy. Mesoporous silica nanoparticles (MSN) and mesoporous organosilica nanoparticles (MON) are attractive candidates due to the ease in controlling the structural parameters as needed for the targeted immunotherapeutic applications. Especially, the MON provide an additional advantage of controlling the composition and modulating the biological functions to actively synergize with other immunotherapeutic strategies. In this review, the applications of MSN, MON, and metal-doped MSN/MON in the field of cancer immunotherapy and tumor microenvironment regulation are comprehensively summarized by highlighting the structural and compositional attributes of the silica-based nanoplatforms.
Cancer is one of the fatal diseases in the history of humankind. In this regard, cancer immunotherapeutic strategies have revolutionized the traditional mode of cancer treatment. Silica based nano-platforms have been extensively applied in nanomedicine including cancer immunotherapy. Mesoporous silica nanoparticles (MSN) and mesoporous organosilica nanoparticles (MON) are attractive candidates due to the ease in controlling the structural parameters as needed for the targeted immunotherapeutic applications. Especially, the MON provide an additional advantage of controlling the composition and modulating the biological functions to actively synergize with other immunotherapeutic strategies. In this review, the applications of MSN, MON, and metal-doped MSN/MON in the field of cancer immunotherapy and tumor microenvironment regulation are comprehensively summarized by highlighting the structural and compositional attributes of the silica-based nanoplatforms.Cancer is one of the fatal diseases in the history of humankind. In this regard, cancer immunotherapeutic strategies have revolutionized the traditional mode of cancer treatment. Silica based nano-platforms have been extensively applied in nanomedicine including cancer immunotherapy. Mesoporous silica nanoparticles (MSN) and mesoporous organosilica nanoparticles (MON) are attractive candidates due to the ease in controlling the structural parameters as needed for the targeted immunotherapeutic applications. Especially, the MON provide an additional advantage of controlling the composition and modulating the biological functions to actively synergize with other immunotherapeutic strategies. In this review, the applications of MSN, MON, and metal-doped MSN/MON in the field of cancer immunotherapy and tumor microenvironment regulation are comprehensively summarized by highlighting the structural and compositional attributes of the silica-based nanoplatforms.
Cancer is one of the fatal diseases in the history of humankind. In this regard, cancer immunotherapeutic strategies have revolutionized the traditional mode of cancer treatment. Silica based nano‐platforms have been extensively applied in nanomedicine including cancer immunotherapy. Mesoporous silica nanoparticles (MSN) and mesoporous organosilica nanoparticles (MON) are attractive candidates due to the ease in controlling the structural parameters as needed for the targeted immunotherapeutic applications. Especially, the MON provide an additional advantage of controlling the composition and modulating the biological functions to actively synergize with other immunotherapeutic strategies. In this review, the applications of MSN, MON, and metal‐doped MSN/MON in the field of cancer immunotherapy and tumor microenvironment regulation are comprehensively summarized by highlighting the structural and compositional attributes of the silica‐based nanoplatforms. Silica based nanoparticles have been extensively applied in nanomedicine including cancer immunotherapy. In this review, the applications of mesoporous silica nanoparticles (MSN), mesoporous organosilica nanoparticles (MON), and metal‐doped MSN/MON in the field of cancer immunotherapy and tumor microenvironment regulation are comprehensively summarized by highlighting the structural and compositional attributes of the silica‐based nanoplatforms.
Abstract Cancer is one of the fatal diseases in the history of humankind. In this regard, cancer immunotherapeutic strategies have revolutionized the traditional mode of cancer treatment. Silica based nano‐platforms have been extensively applied in nanomedicine including cancer immunotherapy. Mesoporous silica nanoparticles (MSN) and mesoporous organosilica nanoparticles (MON) are attractive candidates due to the ease in controlling the structural parameters as needed for the targeted immunotherapeutic applications. Especially, the MON provide an additional advantage of controlling the composition and modulating the biological functions to actively synergize with other immunotherapeutic strategies. In this review, the applications of MSN, MON, and metal‐doped MSN/MON in the field of cancer immunotherapy and tumor microenvironment regulation are comprehensively summarized by highlighting the structural and compositional attributes of the silica‐based nanoplatforms.
Author Yu, Chengzhong
Theivendran, Shevanuja
Lazarev, Sergei
Author_xml – sequence: 1
  givenname: Shevanuja
  surname: Theivendran
  fullname: Theivendran, Shevanuja
  organization: The University of Queensland, Brisbane
– sequence: 2
  givenname: Sergei
  surname: Lazarev
  fullname: Lazarev, Sergei
  organization: The University of Queensland, Brisbane
– sequence: 3
  givenname: Chengzhong
  orcidid: 0000-0003-3707-0785
  surname: Yu
  fullname: Yu, Chengzhong
  email: c.yu@uq.edu.au
  organization: The University of Queensland, Brisbane
BackLink https://www.ncbi.nlm.nih.gov/pubmed/37933387$$D View this record in MEDLINE/PubMed
BookMark eNp9kc1v1DAQxS1URD_ojTOKxIVDt3XGjmMfUbVApSI4gMTNmvUHeJXEwU5U7X-Pt9ntoRKcPGP93vN43jk5GeLgCHlT0-uaUrhZ__x2DRSAUilekDNohVgBVfLkUMuGqlNymfOWFly2IIV8RU5Zqxhjsj0j6y8uxzGmOOcqhy4YvInpFw5xaaqhlCOmKZjO5crHVBkcjEtV6Pt5iNNvl3DcvSYvPXbZXR7OC_Lj4_r77efV_ddPd7cf7leGCyVWNTXWc8u9Nc4hp563DhWAVUJaQGBOeQ-0MALB-hqth7ZxzcaDaHht2AW5W3xtxK0eU-gx7XTEoB8vyuT6MKvmgoM0ihnHJPeyxaYWAstrlANuHr3eL15jin9mlyfdh2xc1-HgyjY0SCkUU6ypC_ruGbqNcxrKTzWjCmRZPt9Tbw_UvOmdfRrvuOwCwAKYFHNOzmsTJpxCHKaEodM11ftQdQlVH0MtoqtnoqPvP_BmwR9C53b_ZffNk-4va8mwzw
CitedBy_id crossref_primary_10_1002_smll_202307310
crossref_primary_10_1360_TB_2024_0670
crossref_primary_10_1002_smll_202400069
crossref_primary_10_1039_D4BM00556B
crossref_primary_10_1021_acs_langmuir_4c01027
crossref_primary_10_3390_pharmaceutics15092239
crossref_primary_10_1039_D3NR05952A
crossref_primary_10_3390_ijms25158066
crossref_primary_10_1002_adma_202306081
crossref_primary_10_1002_adma_202413002
crossref_primary_10_1039_D1CS01022K
crossref_primary_10_1002_advs_202405729
crossref_primary_10_1002_adfm_202502646
crossref_primary_10_3390_molecules30061257
crossref_primary_10_1080_1061186X_2025_2458616
crossref_primary_10_1021_acsami_4c21740
crossref_primary_10_1021_acsnano_4c11453
crossref_primary_10_2147_IJN_S498729
crossref_primary_10_1002_EXP_70012
crossref_primary_10_3390_molecules28237750
crossref_primary_10_3390_polym16223163
crossref_primary_10_1016_j_ijpharm_2023_123700
crossref_primary_10_1021_acs_langmuir_4c03433
crossref_primary_10_3389_fimmu_2024_1440226
crossref_primary_10_1002_smll_202407555
crossref_primary_10_1002_SMMD_20240053
crossref_primary_10_3389_fimmu_2024_1437068
crossref_primary_10_1021_cbe_4c00105
crossref_primary_10_1021_acsami_4c08415
crossref_primary_10_3389_fphar_2024_1518983
crossref_primary_10_1021_acsnano_3c08993
crossref_primary_10_3390_vaccines13020126
crossref_primary_10_1038_s41467_024_55430_4
crossref_primary_10_1021_jacs_4c10997
crossref_primary_10_1007_s40843_024_2932_3
crossref_primary_10_1039_D4BM01038H
Cites_doi 10.1021/cm0011559
10.1002/smll.201001459
10.1186/s12951-021-01073-2
10.1002/adhm.201700831
10.1002/adhm.201900039
10.1038/47229
10.1021/cm504448u
10.1039/D0BM02157A
10.1002/adfm.201800025
10.1021/acs.accounts.0c00280
10.1038/s41590-022-01132-2
10.1016/j.mattod.2017.06.003
10.1016/j.biomaterials.2018.05.025
10.1038/s41577-019-0269-6
10.1002/adma.201604634
10.1016/j.msec.2020.111526
10.1016/j.biomaterials.2020.120191
10.1016/j.biomaterials.2021.120654
10.1002/adfm.201902652
10.3390/s22010261
10.1021/acsnano.0c05392
10.1021/cm011074s
10.3389/fchem.2022.842682
10.1039/C8BM01669K
10.1038/s41467-017-01651-9
10.1038/s41467-019-09158-1
10.1038/359710a0
10.1038/s41568-019-0186-9
10.1021/accountsmr.1c00153
10.1016/j.toxlet.2009.04.017
10.3390/ijms21228605
10.1002/adfm.202002043
10.1016/j.apsb.2020.08.013
10.1021/cm1017344
10.1016/j.colsurfb.2020.111452
10.1016/j.jscs.2017.08.005
10.1016/j.mser.2019.01.001
10.1021/acsami.1c04305
10.1002/smll.202101897
10.1002/adma.201404226
10.1002/anie.202112752
10.1021/acscentsci.8b00035
10.7150/thno.18460
10.1016/j.cclet.2021.06.034
10.1039/D1NR04048K
10.1016/j.mtadv.2020.100069
10.1002/cplu.201600560
10.1021/acsnano.1c00498
10.1039/C7CC08222C
10.1002/smll.201402779
10.1002/mco2.6
10.1038/s41389-017-0011-9
10.1002/adfm.202010637
10.1021/acs.nanolett.0c00713
10.1002/wnan.1573
10.1016/j.biomaterials.2021.120990
10.1021/ja9916658
10.1002/adma.202008065
10.1016/j.micromeso.2009.11.015
10.1186/s12951-021-01025-w
10.1021/ja201779d
10.1016/j.jconrel.2019.08.028
10.1002/smll.201600677
10.1021/acsami.7b16118
10.1126/sciadv.aaz4462
10.1021/acsami.9b19446
10.1016/j.biomaterials.2017.04.028
10.1021/acsnano.0c07071
10.1021/acsami.0c10781
10.7150/thno.19987
10.1002/adma.201505524
10.1021/tx300166u
10.1016/j.biomaterials.2016.03.019
10.1039/D0BM01452D
10.1038/s41422-020-0337-2
10.1002/smll.202100006
10.1039/D0BM01168A
10.1016/j.micromeso.2010.01.009
10.1021/cm402592t
10.1038/s41598-017-03834-2
10.1002/advs.201901690
10.1016/j.biomaterials.2022.121368
10.1016/j.jcis.2011.05.038
10.1021/cm502777e
10.1021/ja3116873
10.1146/annurev-cancerbio-030518-055552
10.1002/adma.202004385
10.1016/j.cej.2020.126936
10.1002/anie.201701550
10.1016/j.phrs.2020.104742
10.1021/cm0204371
10.1080/02603594.2015.1088439
10.1021/cm9903935
10.1021/la302145j
10.1039/D1CS00659B
10.1021/acs.chemmater.5b03963
10.1016/j.jcis.2018.08.088
10.1039/c3cs35405a
10.1038/s41571-019-0308-z
10.1002/chem.201600587
10.1002/anie.201712027
10.1021/acsnano.2c03348
10.3389/fchem.2019.00290
10.1002/adtp.202000130
10.3389/fchem.2020.598722
10.1002/adma.201104763
10.1021/nn200365a
10.3390/biom10101429
10.1039/C8TB00544C
10.1016/j.apmt.2019.05.006
10.1016/j.semcancer.2017.03.001
10.1021/ar3000986
10.1021/acscentsci.8b00181
10.1016/j.biomaterials.2018.01.046
10.1016/j.msec.2021.112232
10.1016/j.addr.2012.07.018
10.1002/anie.201807595
10.1021/acs.nanolett.9b02448
10.1021/ar200343s
10.1016/j.biomaterials.2020.119859
10.1039/D0SC02803G
ContentType Journal Article
Copyright 2023 The Authors. published by Henan University and John Wiley & Sons Australia, Ltd.
2023 The Authors. Exploration published by Henan University and John Wiley & Sons Australia, Ltd.
2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the "License"). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: 2023 The Authors. published by Henan University and John Wiley & Sons Australia, Ltd.
– notice: 2023 The Authors. Exploration published by Henan University and John Wiley & Sons Australia, Ltd.
– notice: 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the "License"). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID 24P
AAYXX
CITATION
NPM
ABUWG
AEUYN
AFKRA
ATCPS
AZQEC
BENPR
BHPHI
CCPQU
DWQXO
GNUQQ
HCIFZ
PATMY
PHGZM
PHGZT
PIMPY
PKEHL
PQEST
PQQKQ
PQUKI
PRINS
PYCSY
7X8
DOA
DOI 10.1002/EXP.20220086
DatabaseName Wiley Online Library Open Access
CrossRef
PubMed
ProQuest Central (Alumni)
ProQuest One Sustainability (subscription)
ProQuest Central UK/Ireland
Agricultural & Environmental Science Collection
ProQuest Central Essentials
ProQuest Central
Natural Science Collection
ProQuest One Community College
ProQuest Central Korea
ProQuest Central Student
SciTech Premium Collection
Environmental Science Database
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
Environmental Science Collection
MEDLINE - Academic
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
Publicly Available Content Database
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest Central China
ProQuest Central
Environmental Science Collection
ProQuest One Sustainability
ProQuest One Academic UKI Edition
Natural Science Collection
ProQuest Central Korea
Agricultural & Environmental Science Collection
Environmental Science Database
ProQuest Central (New)
ProQuest One Academic
ProQuest One Academic (New)
MEDLINE - Academic
DatabaseTitleList PubMed
CrossRef
Publicly Available Content Database
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: 24P
  name: Wiley Online Library Open Access
  url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html
  sourceTypes: Publisher
– sequence: 3
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 2766-2098
EndPage n/a
ExternalDocumentID oai_doaj_org_article_46428c93ce384f87a5166aa92042ab1c
37933387
10_1002_EXP_20220086
EXP20220086
Genre reviewArticle
Journal Article
Review
GrantInformation_xml – fundername: Queensland Government
– fundername: Australian Research Council
– fundername: the University of Queensland and the Queensland node of the Australian National Fabrication Facility
GroupedDBID 0R~
1OC
24P
AAHHS
ACCFJ
ACCMX
ADZOD
AEEZP
AEQDE
AEUYN
AFKRA
AIWBW
AJBDE
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ARCSS
ATCPS
BENPR
BHPHI
CCPQU
EBS
GROUPED_DOAJ
HCIFZ
M~E
OK1
PATMY
PIMPY
PYCSY
RPM
AAYXX
CITATION
PHGZM
PHGZT
NPM
AAMMB
ABUWG
AEFGJ
AGXDD
AIDQK
AIDYY
AZQEC
DWQXO
GNUQQ
PKEHL
PQEST
PQQKQ
PQUKI
PRINS
7X8
PUEGO
WIN
ID FETCH-LOGICAL-c4696-10cdf4d4fdceea40f47ea922d968d2a23e9ff20df46a2df1adf275e5bf26541c3
IEDL.DBID 24P
ISSN 2766-8509
2766-2098
IngestDate Wed Aug 27 01:29:09 EDT 2025
Fri Jul 11 12:13:17 EDT 2025
Sat Jul 26 02:36:00 EDT 2025
Thu Apr 03 07:04:21 EDT 2025
Tue Jul 01 01:52:18 EDT 2025
Thu Apr 24 23:11:57 EDT 2025
Wed Jan 22 16:20:34 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords cancer
organosilica
nanoparticles
silica
immunotherapy
Language English
License Attribution
2023 The Authors. Exploration published by Henan University and John Wiley & Sons Australia, Ltd.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4696-10cdf4d4fdceea40f47ea922d968d2a23e9ff20df46a2df1adf275e5bf26541c3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ORCID 0000-0003-3707-0785
OpenAccessLink https://onlinelibrary.wiley.com/doi/abs/10.1002%2FEXP.20220086
PMID 37933387
PQID 3092808641
PQPubID 6853494
PageCount 18
ParticipantIDs doaj_primary_oai_doaj_org_article_46428c93ce384f87a5166aa92042ab1c
proquest_miscellaneous_2886939351
proquest_journals_3092808641
pubmed_primary_37933387
crossref_citationtrail_10_1002_EXP_20220086
crossref_primary_10_1002_EXP_20220086
wiley_primary_10_1002_EXP_20220086_EXP20220086
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate June 2023
2023-06-00
2023-Jun
20230601
2023-06-01
PublicationDateYYYYMMDD 2023-06-01
PublicationDate_xml – month: 06
  year: 2023
  text: June 2023
PublicationDecade 2020
PublicationPlace China
PublicationPlace_xml – name: China
– name: Beijing
PublicationTitle Exploration (Beijing, China)
PublicationTitleAlternate Exploration (Beijing)
PublicationYear 2023
Publisher John Wiley & Sons, Inc
Wiley
Publisher_xml – name: John Wiley & Sons, Inc
– name: Wiley
References 2002; 14
2017; 82
2018; 161
2020; 20
2013; 65
2019; 11
2019; 10
2020; 17
2022; 23
2014; 26
2019; 16
2019; 19
2020; 14
2020; 12
2020; 11
2022; 22
2020; 10
2016; 36
2018; 7
2018; 175
2018; 6
2010; 22
2022; 281
2018; 4
1992; 359
2019; 29
2012; 28
2021; 275
2011; 361
2012; 25
2012; 24
2019; 311‐312
2019; 8
2019; 7
2018; 28
2019; 3
2019; 6
2021; 269
2016; 91
2020; 32
2017; 133
2018; 22
2011; 5
2011; 7
2011; 133
2016; 12
2020; 30
2017; 56
2009; 189
2020; 155
2022; 10
2020; 21
2016; 28
2012; 45
2022; 16
2016; 22
2017; 7
2017; 8
2017; 43
2021; 127
2021; 405
1999; 121
1999; 402
2017; 9
2016; 79
2020; 8
2020; 6
2021; 32
2020; 3
2021; 31
2020; 1
2021; 33
2020; 53
2021; 118
1999; 11
2021; 197
2020; 256
2001; 13
2021; 9
2017; 20
2021; 2
2013; 46
2022; 51
2013; 42
2015; 11
2017; 29
2021; 13
2021; 15
2015; 27
2021; 11
2022; 61
2021; 17
2021; 19
2019; 137
2019; 533
2010; 132
2020; 239
2013; 135
2010; 131
2011; 47
2018; 54
2018; 57
e_1_2_9_75_1
e_1_2_9_98_1
e_1_2_9_52_1
e_1_2_9_79_1
e_1_2_9_94_1
e_1_2_9_10_1
e_1_2_9_56_1
e_1_2_9_33_1
e_1_2_9_90_1
e_1_2_9_71_1
e_1_2_9_103_1
e_1_2_9_107_1
e_1_2_9_14_1
e_1_2_9_37_1
e_1_2_9_18_1
e_1_2_9_41_1
e_1_2_9_64_1
e_1_2_9_87_1
e_1_2_9_22_1
e_1_2_9_45_1
e_1_2_9_68_1
e_1_2_9_83_1
e_1_2_9_6_1
Lin Y.‐S. (e_1_2_9_122_1) 2011; 47
e_1_2_9_119_1
e_1_2_9_60_1
e_1_2_9_2_1
Braun K. (e_1_2_9_118_1) 2016; 79
e_1_2_9_111_1
e_1_2_9_115_1
e_1_2_9_26_1
e_1_2_9_49_1
e_1_2_9_30_1
e_1_2_9_53_1
e_1_2_9_99_1
e_1_2_9_72_1
e_1_2_9_11_1
e_1_2_9_34_1
e_1_2_9_57_1
e_1_2_9_95_1
e_1_2_9_76_1
e_1_2_9_91_1
e_1_2_9_102_1
e_1_2_9_106_1
e_1_2_9_15_1
e_1_2_9_38_1
Song H. (e_1_2_9_36_1) 2022; 10
e_1_2_9_121_1
e_1_2_9_19_1
e_1_2_9_42_1
e_1_2_9_88_1
e_1_2_9_61_1
e_1_2_9_46_1
e_1_2_9_84_1
e_1_2_9_23_1
e_1_2_9_65_1
e_1_2_9_80_1
e_1_2_9_5_1
e_1_2_9_114_1
e_1_2_9_9_1
e_1_2_9_27_1
e_1_2_9_69_1
e_1_2_9_110_1
e_1_2_9_31_1
e_1_2_9_50_1
e_1_2_9_73_1
e_1_2_9_35_1
e_1_2_9_77_1
e_1_2_9_96_1
e_1_2_9_12_1
e_1_2_9_54_1
e_1_2_9_92_1
e_1_2_9_109_1
Croissant J. G. (e_1_2_9_20_1) 2016; 22
e_1_2_9_101_1
e_1_2_9_105_1
e_1_2_9_124_1
e_1_2_9_39_1
e_1_2_9_120_1
e_1_2_9_16_1
e_1_2_9_58_1
e_1_2_9_62_1
e_1_2_9_89_1
e_1_2_9_24_1
e_1_2_9_43_1
e_1_2_9_66_1
e_1_2_9_85_1
e_1_2_9_8_1
e_1_2_9_81_1
e_1_2_9_4_1
e_1_2_9_113_1
e_1_2_9_117_1
e_1_2_9_28_1
e_1_2_9_47_1
e_1_2_9_74_1
e_1_2_9_51_1
e_1_2_9_78_1
e_1_2_9_13_1
e_1_2_9_32_1
e_1_2_9_55_1
e_1_2_9_97_1
e_1_2_9_93_1
e_1_2_9_108_1
e_1_2_9_70_1
e_1_2_9_100_1
e_1_2_9_123_1
e_1_2_9_104_1
e_1_2_9_17_1
e_1_2_9_59_1
e_1_2_9_63_1
e_1_2_9_40_1
e_1_2_9_21_1
e_1_2_9_67_1
e_1_2_9_44_1
e_1_2_9_86_1
e_1_2_9_7_1
e_1_2_9_82_1
e_1_2_9_3_1
e_1_2_9_112_1
e_1_2_9_116_1
e_1_2_9_25_1
e_1_2_9_48_1
e_1_2_9_29_1
References_xml – volume: 13
  year: 2021
  publication-title: ACS Appl. Mater. Interfaces
– volume: 65
  start-page: 689
  year: 2013
  publication-title: Adv. Drug Delivery Rev.
– volume: 155
  year: 2020
  publication-title: Pharmacol. Res.
– volume: 137
  start-page: 66
  year: 2019
  publication-title: Mater. Sci. Eng., R
– volume: 22
  start-page: 405
  year: 2018
  publication-title: J. Saudi Chem. Soc.
– volume: 21
  start-page: 8605
  year: 2020
  publication-title: Int. J. Mol. Sci.
– volume: 12
  year: 2020
  publication-title: ACS Appl. Mater. Interfaces
– volume: 19
  start-page: 587
  year: 2019
  publication-title: Nat. Rev. Cancer
– volume: 11
  year: 2020
  publication-title: Chem. Sci.
– volume: 51
  start-page: 5365
  year: 2022
  publication-title: Chem. Soc. Rev.
– volume: 10
  start-page: 1241
  year: 2019
  publication-title: Nat. Commun.
– volume: 189
  start-page: 177
  year: 2009
  publication-title: Toxicol. Lett.
– volume: 402
  start-page: 867
  year: 1999
  publication-title: Nature
– volume: 7
  start-page: 271
  year: 2011
  publication-title: Small
– volume: 7
  year: 2018
  publication-title: Adv. Healthcare Mater.
– volume: 11
  start-page: 520
  year: 2021
  publication-title: Acta Pharm. Sin. B
– volume: 14
  year: 2020
  publication-title: ACS Nano
– volume: 1
  start-page: 47
  year: 2020
  publication-title: MedComm
– volume: 30
  year: 2020
  publication-title: Adv. Funct. Mater.
– volume: 17
  start-page: 251
  year: 2020
  publication-title: Nat. Rev. Clin. Oncol.
– volume: 8
  year: 2019
  publication-title: Adv. Healthcare Mater.
– volume: 29
  year: 2019
  publication-title: Adv. Funct. Mater.
– volume: 20
  start-page: 321
  year: 2020
  publication-title: Nat. Rev. Immunol.
– volume: 8
  year: 2020
  publication-title: Front. Chem.
– volume: 8
  start-page: 6272
  year: 2020
  publication-title: Biomater. Sci.
– volume: 269
  year: 2021
  publication-title: Biomaterials
– volume: 6
  year: 2019
  publication-title: Adv. Sci.
– volume: 10
  start-page: 1429
  year: 2020
  publication-title: Biomolecules
– volume: 2
  start-page: 1190
  year: 2021
  publication-title: Acc. Mater. Res.
– volume: 22
  start-page: 261
  year: 2022
  publication-title: Sensors
– volume: 7
  start-page: 3007
  year: 2017
  publication-title: Theranostics
– volume: 15
  start-page: 8039
  year: 2021
  publication-title: ACS Nano
– volume: 405
  year: 2021
  publication-title: J. Chem. Eng.
– volume: 7
  start-page: 4131
  year: 2017
  publication-title: Sci. Rep.
– volume: 361
  start-page: 16
  year: 2011
  publication-title: J. Colloid Interface Sci.
– volume: 161
  start-page: 292
  year: 2018
  publication-title: Biomaterials
– volume: 20
  start-page: 346
  year: 2017
  publication-title: Mater. Today
– volume: 6
  year: 2020
  publication-title: Sci. Adv.
– volume: 533
  start-page: 463
  year: 2019
  publication-title: J. Colloid Interface Sci.
– volume: 7
  start-page: 10
  year: 2018
  publication-title: Oncogenesis
– volume: 9
  start-page: 917
  year: 2021
  publication-title: Biomater. Sci.
– volume: 17
  year: 2021
  publication-title: Small
– volume: 91
  start-page: 90
  year: 2016
  publication-title: Biomaterials
– volume: 281
  year: 2022
  publication-title: Biomaterials
– volume: 61
  year: 2022
  publication-title: Angew. Chem., Int. Ed.
– volume: 127
  year: 2021
  publication-title: Mater. Sci. Eng., C
– volume: 11
  year: 2019
  publication-title: Wiley Interdiscip. Rev.: Nanomed. Nanobiotechnol.
– volume: 11
  year: 2019
  publication-title: ACS Appl. Mater. Interfaces
– volume: 45
  start-page: 1678
  year: 2012
  publication-title: Acc. Chem. Res.
– volume: 118
  year: 2021
  publication-title: Mater. Sci. Eng., C
– volume: 11
  start-page: 2743
  year: 2015
  publication-title: Small
– volume: 13
  start-page: 3306
  year: 2001
  publication-title: Chem. Mater.
– volume: 22
  start-page: 9607
  year: 2016
  publication-title: Eur. J. Chem.
– volume: 22
  start-page: 5093
  year: 2010
  publication-title: Chem. Mater.
– volume: 275
  year: 2021
  publication-title: Biomaterials
– volume: 32
  year: 2020
  publication-title: Adv. Mater.
– volume: 31
  year: 2021
  publication-title: Adv. Funct. Mater.
– volume: 19
  start-page: 328
  year: 2021
  publication-title: J. Nanobiotechnol.
– volume: 24
  start-page: 1504
  year: 2012
  publication-title: Adv. Mater.
– volume: 57
  year: 2018
  publication-title: Angew. Chem., Int. Ed.
– volume: 25
  start-page: 2265
  year: 2012
  publication-title: Chem. Res. Toxicol.
– volume: 311‐312
  start-page: 1
  year: 2019
  publication-title: J. Controlled Release
– volume: 57
  start-page: 4902
  year: 2018
  publication-title: Angew. Chem., Int. Ed.
– volume: 10
  year: 2022
  publication-title: Front. Chem.
– volume: 197
  year: 2021
  publication-title: Colloids Surf., B
– volume: 42
  start-page: 3862
  year: 2013
  publication-title: Chem. Soc. Rev.
– volume: 82
  start-page: 631
  year: 2017
  publication-title: ChemPlusChem
– volume: 359
  start-page: 710
  year: 1992
  publication-title: Nature
– volume: 30
  start-page: 507
  year: 2020
  publication-title: Cell Res.
– volume: 28
  start-page: 704
  year: 2016
  publication-title: Chem. Mater.
– volume: 133
  start-page: 219
  year: 2017
  publication-title: Biomaterials
– volume: 54
  start-page: 1057
  year: 2018
  publication-title: Chem. Commun.
– volume: 20
  start-page: 6246
  year: 2020
  publication-title: Nano Lett.
– volume: 131
  start-page: 314
  year: 2010
  publication-title: Microporous Mesoporous Mater.
– volume: 239
  year: 2020
  publication-title: Biomaterials
– volume: 175
  start-page: 82
  year: 2018
  publication-title: Biomaterials
– volume: 7
  start-page: 1825
  year: 2019
  publication-title: Biomater. Sci.
– volume: 16
  start-page: 102
  year: 2019
  publication-title: Appl. Mater. Today
– volume: 12
  start-page: 3510
  year: 2016
  publication-title: Small
– volume: 36
  start-page: 61
  year: 2016
  publication-title: Comments Inorg. Chem.
– volume: 33
  year: 2021
  publication-title: Adv. Mater.
– volume: 56
  start-page: 8446
  year: 2017
  publication-title: Angew. Chem., Int. Ed.
– volume: 5
  start-page: 5390
  year: 2011
  publication-title: ACS Nano
– volume: 3
  start-page: 55
  year: 2019
  publication-title: Annu. Rev. Cancer Biol.
– volume: 121
  start-page: 9611
  year: 1999
  publication-title: J. Am. Chem. Soc.
– volume: 14
  start-page: 4721
  year: 2002
  publication-title: Chem. Mater.
– volume: 28
  year: 2012
  publication-title: Langmuir
– volume: 28
  year: 2018
  publication-title: Adv. Funct. Mater.
– volume: 79
  start-page: 319
  year: 2016
  publication-title: .
– volume: 13
  year: 2021
  publication-title: Nanoscale
– volume: 6
  year: 2020
  publication-title: Mater. Today Adv.
– volume: 53
  start-page: 1545
  year: 2020
  publication-title: Acc. Chem. Res.
– volume: 7
  start-page: 290
  year: 2019
  publication-title: Front. Chem.
– volume: 26
  start-page: 5980
  year: 2014
  publication-title: Chem. Mater.
– volume: 4
  start-page: 484
  year: 2018
  publication-title: ACS Cent. Sci.
– volume: 19
  start-page: 8409
  year: 2019
  publication-title: Nano Lett.
– volume: 29
  year: 2017
  publication-title: Adv. Mater.
– volume: 133
  start-page: 8102
  year: 2011
  publication-title: J. Am. Chem. Soc.
– volume: 13
  start-page: 308
  year: 2001
  publication-title: Chem. Mater.
– volume: 27
  start-page: 3193
  year: 2015
  publication-title: Chem. Mater.
– volume: 16
  year: 2022
  publication-title: ACS Nano
– volume: 28
  start-page: 1963
  year: 2016
  publication-title: Adv. Mater.
– volume: 19
  start-page: 290
  year: 2021
  publication-title: J. Nanobiotechnol.
– volume: 135
  start-page: 2427
  year: 2013
  publication-title: J. Am. Chem. Soc.
– volume: 26
  start-page: 435
  year: 2014
  publication-title: Chem. Mater.
– volume: 8
  start-page: 1811
  year: 2017
  publication-title: Nat. Commun.
– volume: 43
  start-page: 74
  year: 2017
  publication-title: Semin. Cancer Biol.
– volume: 23
  start-page: 487
  year: 2022
  publication-title: Nat. Immunol.
– volume: 11
  start-page: 3302
  year: 1999
  publication-title: Chem. Mater.
– volume: 256
  year: 2020
  publication-title: Biomaterials
– volume: 9
  year: 2017
  publication-title: ACS Appl. Mater. Interfaces
– volume: 47
  start-page: 532
  year: 2011
  publication-title: Chem
– volume: 32
  start-page: 3696
  year: 2021
  publication-title: Chin. Chem. Lett.
– volume: 7
  start-page: 3276
  year: 2017
  publication-title: Theranostics
– volume: 4
  start-page: 527
  year: 2018
  publication-title: ACS Cent. Sci.
– volume: 9
  start-page: 1609
  year: 2021
  publication-title: Biomater. Sci.
– volume: 27
  start-page: 145
  year: 2015
  publication-title: Adv. Mater.
– volume: 3
  year: 2020
  publication-title: Adv. Ther.
– volume: 132
  start-page: 60
  year: 2010
  publication-title: Microporous Mesoporous Mater.
– volume: 6
  start-page: 4089
  year: 2018
  publication-title: J. Mater. Chem. B
– volume: 46
  start-page: 792
  year: 2013
  publication-title: Acc. Chem. Res.
– ident: e_1_2_9_7_1
  doi: 10.1021/cm0011559
– ident: e_1_2_9_15_1
  doi: 10.1002/smll.201001459
– ident: e_1_2_9_98_1
  doi: 10.1186/s12951-021-01073-2
– ident: e_1_2_9_60_1
  doi: 10.1002/adhm.201700831
– ident: e_1_2_9_38_1
  doi: 10.1002/adhm.201900039
– ident: e_1_2_9_16_1
  doi: 10.1038/47229
– ident: e_1_2_9_53_1
  doi: 10.1021/cm504448u
– ident: e_1_2_9_45_1
  doi: 10.1039/D0BM02157A
– ident: e_1_2_9_78_1
  doi: 10.1002/adfm.201800025
– ident: e_1_2_9_71_1
  doi: 10.1021/acs.accounts.0c00280
– ident: e_1_2_9_75_1
  doi: 10.1038/s41590-022-01132-2
– ident: e_1_2_9_79_1
  doi: 10.1016/j.mattod.2017.06.003
– ident: e_1_2_9_108_1
  doi: 10.1016/j.biomaterials.2018.05.025
– ident: e_1_2_9_27_1
  doi: 10.1038/s41577-019-0269-6
– ident: e_1_2_9_115_1
  doi: 10.1002/adma.201604634
– ident: e_1_2_9_24_1
  doi: 10.1016/j.msec.2020.111526
– ident: e_1_2_9_25_1
  doi: 10.1016/j.biomaterials.2020.120191
– ident: e_1_2_9_86_1
  doi: 10.1016/j.biomaterials.2021.120654
– ident: e_1_2_9_6_1
  doi: 10.1002/adfm.201902652
– ident: e_1_2_9_5_1
  doi: 10.3390/s22010261
– ident: e_1_2_9_93_1
  doi: 10.1021/acsnano.0c05392
– ident: e_1_2_9_46_1
  doi: 10.1021/cm011074s
– volume: 10
  year: 2022
  ident: e_1_2_9_36_1
  publication-title: Front. Chem.
  doi: 10.3389/fchem.2022.842682
– ident: e_1_2_9_35_1
  doi: 10.1039/C8BM01669K
– ident: e_1_2_9_77_1
  doi: 10.1038/s41467-017-01651-9
– ident: e_1_2_9_70_1
  doi: 10.1038/s41467-019-09158-1
– ident: e_1_2_9_2_1
  doi: 10.1038/359710a0
– ident: e_1_2_9_32_1
  doi: 10.1038/s41568-019-0186-9
– ident: e_1_2_9_4_1
  doi: 10.1021/accountsmr.1c00153
– ident: e_1_2_9_117_1
  doi: 10.1016/j.toxlet.2009.04.017
– ident: e_1_2_9_11_1
  doi: 10.3390/ijms21228605
– ident: e_1_2_9_23_1
  doi: 10.1002/adfm.202002043
– ident: e_1_2_9_82_1
  doi: 10.1016/j.apsb.2020.08.013
– ident: e_1_2_9_67_1
  doi: 10.1021/cm1017344
– ident: e_1_2_9_76_1
  doi: 10.1016/j.colsurfb.2020.111452
– ident: e_1_2_9_61_1
  doi: 10.1016/j.jscs.2017.08.005
– ident: e_1_2_9_43_1
  doi: 10.1016/j.mser.2019.01.001
– ident: e_1_2_9_83_1
  doi: 10.1021/acsami.1c04305
– ident: e_1_2_9_80_1
  doi: 10.1002/smll.202101897
– ident: e_1_2_9_59_1
  doi: 10.1002/adma.201404226
– ident: e_1_2_9_65_1
  doi: 10.1002/anie.202112752
– ident: e_1_2_9_74_1
  doi: 10.1021/acscentsci.8b00035
– ident: e_1_2_9_85_1
  doi: 10.7150/thno.18460
– ident: e_1_2_9_13_1
  doi: 10.1016/j.cclet.2021.06.034
– ident: e_1_2_9_3_1
  doi: 10.1039/D1NR04048K
– ident: e_1_2_9_109_1
  doi: 10.1016/j.mtadv.2020.100069
– ident: e_1_2_9_57_1
  doi: 10.1002/cplu.201600560
– ident: e_1_2_9_34_1
  doi: 10.1021/acsnano.1c00498
– ident: e_1_2_9_102_1
  doi: 10.1039/C7CC08222C
– ident: e_1_2_9_55_1
  doi: 10.1002/smll.201402779
– ident: e_1_2_9_30_1
  doi: 10.1002/mco2.6
– ident: e_1_2_9_41_1
  doi: 10.1038/s41389-017-0011-9
– ident: e_1_2_9_92_1
  doi: 10.1002/adfm.202010637
– ident: e_1_2_9_104_1
  doi: 10.1021/acs.nanolett.0c00713
– ident: e_1_2_9_9_1
  doi: 10.1002/wnan.1573
– ident: e_1_2_9_88_1
  doi: 10.1016/j.biomaterials.2021.120990
– ident: e_1_2_9_17_1
  doi: 10.1021/ja9916658
– ident: e_1_2_9_99_1
  doi: 10.1002/adma.202008065
– ident: e_1_2_9_123_1
  doi: 10.1016/j.micromeso.2009.11.015
– ident: e_1_2_9_21_1
  doi: 10.1186/s12951-021-01025-w
– ident: e_1_2_9_124_1
  doi: 10.1021/ja201779d
– ident: e_1_2_9_119_1
  doi: 10.1016/j.jconrel.2019.08.028
– ident: e_1_2_9_101_1
  doi: 10.1002/smll.201600677
– volume: 79
  start-page: 319
  year: 2016
  ident: e_1_2_9_118_1
  publication-title: .
– ident: e_1_2_9_94_1
  doi: 10.1021/acsami.7b16118
– ident: e_1_2_9_72_1
  doi: 10.1126/sciadv.aaz4462
– ident: e_1_2_9_95_1
  doi: 10.1021/acsami.9b19446
– ident: e_1_2_9_113_1
  doi: 10.1016/j.biomaterials.2017.04.028
– ident: e_1_2_9_110_1
  doi: 10.1021/acsnano.0c07071
– ident: e_1_2_9_91_1
  doi: 10.1021/acsami.0c10781
– ident: e_1_2_9_97_1
  doi: 10.7150/thno.19987
– ident: e_1_2_9_112_1
  doi: 10.1002/adma.201505524
– ident: e_1_2_9_116_1
  doi: 10.1021/tx300166u
– ident: e_1_2_9_19_1
  doi: 10.1016/j.biomaterials.2016.03.019
– ident: e_1_2_9_87_1
  doi: 10.1039/D0BM01452D
– ident: e_1_2_9_29_1
  doi: 10.1038/s41422-020-0337-2
– ident: e_1_2_9_105_1
  doi: 10.1002/smll.202100006
– ident: e_1_2_9_100_1
  doi: 10.1039/D0BM01168A
– ident: e_1_2_9_120_1
  doi: 10.1016/j.micromeso.2010.01.009
– ident: e_1_2_9_64_1
  doi: 10.1021/cm402592t
– ident: e_1_2_9_62_1
  doi: 10.1038/s41598-017-03834-2
– ident: e_1_2_9_103_1
  doi: 10.1002/advs.201901690
– ident: e_1_2_9_106_1
  doi: 10.1016/j.biomaterials.2022.121368
– ident: e_1_2_9_54_1
  doi: 10.1016/j.jcis.2011.05.038
– ident: e_1_2_9_68_1
  doi: 10.1021/cm502777e
– ident: e_1_2_9_63_1
  doi: 10.1021/ja3116873
– ident: e_1_2_9_28_1
  doi: 10.1146/annurev-cancerbio-030518-055552
– ident: e_1_2_9_33_1
  doi: 10.1002/adma.202004385
– ident: e_1_2_9_56_1
  doi: 10.1016/j.cej.2020.126936
– volume: 47
  start-page: 532
  year: 2011
  ident: e_1_2_9_122_1
  publication-title: Chem
– ident: e_1_2_9_107_1
  doi: 10.1002/anie.201701550
– ident: e_1_2_9_26_1
  doi: 10.1016/j.phrs.2020.104742
– ident: e_1_2_9_48_1
  doi: 10.1021/cm0204371
– ident: e_1_2_9_114_1
  doi: 10.1080/02603594.2015.1088439
– ident: e_1_2_9_18_1
  doi: 10.1021/cm9903935
– ident: e_1_2_9_52_1
  doi: 10.1021/la302145j
– ident: e_1_2_9_44_1
  doi: 10.1039/D1CS00659B
– ident: e_1_2_9_50_1
  doi: 10.1021/acs.chemmater.5b03963
– ident: e_1_2_9_121_1
  doi: 10.1016/j.jcis.2018.08.088
– ident: e_1_2_9_51_1
  doi: 10.1039/c3cs35405a
– ident: e_1_2_9_31_1
  doi: 10.1038/s41571-019-0308-z
– volume: 22
  start-page: 9607
  year: 2016
  ident: e_1_2_9_20_1
  publication-title: Eur. J. Chem.
  doi: 10.1002/chem.201600587
– ident: e_1_2_9_39_1
  doi: 10.1002/anie.201712027
– ident: e_1_2_9_111_1
  doi: 10.1021/acsnano.2c03348
– ident: e_1_2_9_10_1
  doi: 10.3389/fchem.2019.00290
– ident: e_1_2_9_89_1
  doi: 10.1002/adtp.202000130
– ident: e_1_2_9_12_1
  doi: 10.3389/fchem.2020.598722
– ident: e_1_2_9_14_1
  doi: 10.1002/adma.201104763
– ident: e_1_2_9_22_1
  doi: 10.1021/nn200365a
– ident: e_1_2_9_40_1
  doi: 10.3390/biom10101429
– ident: e_1_2_9_47_1
  doi: 10.1039/C8TB00544C
– ident: e_1_2_9_81_1
  doi: 10.1016/j.apmt.2019.05.006
– ident: e_1_2_9_42_1
  doi: 10.1016/j.semcancer.2017.03.001
– ident: e_1_2_9_66_1
  doi: 10.1021/ar3000986
– ident: e_1_2_9_73_1
  doi: 10.1021/acscentsci.8b00181
– ident: e_1_2_9_58_1
  doi: 10.1016/j.biomaterials.2018.01.046
– ident: e_1_2_9_69_1
  doi: 10.1016/j.msec.2021.112232
– ident: e_1_2_9_8_1
  doi: 10.1016/j.addr.2012.07.018
– ident: e_1_2_9_37_1
  doi: 10.1002/anie.201807595
– ident: e_1_2_9_84_1
  doi: 10.1021/acs.nanolett.9b02448
– ident: e_1_2_9_49_1
  doi: 10.1021/ar200343s
– ident: e_1_2_9_90_1
  doi: 10.1016/j.biomaterials.2020.119859
– ident: e_1_2_9_96_1
  doi: 10.1039/D0SC02803G
SSID ssj0002872868
Score 2.4571908
SecondaryResourceType review_article
Snippet Cancer is one of the fatal diseases in the history of humankind. In this regard, cancer immunotherapeutic strategies have revolutionized the traditional mode...
Abstract Cancer is one of the fatal diseases in the history of humankind. In this regard, cancer immunotherapeutic strategies have revolutionized the...
SourceID doaj
proquest
pubmed
crossref
wiley
SourceType Open Website
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 20220086
SubjectTerms Cancer
Cancer immunotherapy
Cancer therapies
Drug delivery systems
Hydrocarbons
Immunotherapy
Morphology
Nanoparticles
Nanotechnology
organosilica
Pore size
Side effects
Silica
Silicon dioxide
Surfactants
Synergism
Tumor microenvironment
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Li9swEBZlodDL0ufW27S40D0tbuyxZcnHtmRZCik9NJCbkPWALMUJSXrIv--MZJsEdruX3mR7sKRvbM2MHvMx9klY7Z0gjjBoZIYWv85aByIDA9ZbIzkPlCzzH_Xtovq-5Msjqi_aExbTA0fgphU5yKYpjStl5aXQHN-ndQP4tem2MDT6os07CqbuwpSRABnOwYHA6iWaxX7XOz6bzpY_MTIEWvqvT-xRSNt_n6956roG23PznJ33TmP6JTb2BXviupfsaaSRPLxis7nbrdGPxiA-3a1oFm4ayJrW8SLtsLgZdsCl6KWmhnS9TVd0OKQ_gnV4zRY3s1_fbrOeHiEzGNPWOIAa6ytbIaTO6Sr3lXCIC9imlhY0lK7xHnKUqTUCX2jrQXDHWw9E_m3KN-ysW3fuLUsttLWgJcDCo0fVyjY3upA5t5wbSiGYsOsBJGX63OFEYfFbxazHoBBSNUCasKtRehNzZjwg95XwHmUo03W4gRipHhX1mP4TNhm0pfrfb6fKvAGJNVRFwj6Oj_HHodUQ3TnUhwIp64YOJqPMRdTy2JISRy2M3UXCPge1_7MbdDGUL_9Hl96xZ0RqHzekTdjZfvvHvUfXZ99-CF_5XyhI-ek
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: ProQuest Central
  dbid: BENPR
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3Na90wDBfrK4NexrZ2W7puZLCeSvYSJY6d01jHK2XQUkoL72Ycf0Ch5L31dYf-95USJ6Ow9RbHOtiSLUuyrB_AV-lM8JIxwrBRGZ34ddZ6lBladMFZJUQPyXJ2Xp9eV7-WYhkDbpuYVjnqxF5Ru5XlGPm8zBtUZH9Xxff174xRo_h2NUJobME2qWClZrB9vDi_uJyiLOQPoOrfw6GkYWDeqJj9Tn3zxfKCPETkFID6ybnUl-__l8351ITtz6CT1_AqGo_pj0Hab-CF797CywFO8mEXFmd-syJ7mpz5dHPD0bh5D9q0GhppR5_rMRMuJWs1tSzzu_SGH4nEp1gPe3B9srj6eZpFmITMkm9bkyK1LlSuItZ6b6o8VNKbBtE1tXJosPRNCJgTTW1IAIVxAaXwog3IIOC2fAezbtX5D5A6bGvJV4FFIMuqVW1uTaFy4YSwXEowgaORSdrGGuIMZXGrh-rHqImlemRpAocT9XqonfEfumPm90TDFa_7H8QjHbmiK3aUbFNaX6oqKGkErStD8yStY9rCJnAwSkvHbbjRfxdNAl-mbtpAfCtiOk_y0LRs6oYfKBPN-0HK00hK0l7kw8sEvvVif3Ya3Bi_958fzUfYYdj6IeXsAGb3d3_8JzJu7tvPcQU_AukW83Y
  priority: 102
  providerName: ProQuest
Title Mesoporous silica/organosilica nanoparticles for cancer immunotherapy
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2FEXP.20220086
https://www.ncbi.nlm.nih.gov/pubmed/37933387
https://www.proquest.com/docview/3092808641
https://www.proquest.com/docview/2886939351
https://doaj.org/article/46428c93ce384f87a5166aa92042ab1c
Volume 3
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlR3LatwwcGgTCr2UJn25TRYX2lMxa48lSz42ZUMIJCylgb0JWQ8IFG_Ipof8fWfkRxtoC71J1tiWZiTNQ5oZgA_K2xgU5wjDVhfE8ZuiC6gKdOijd1rKlJLl4rI5uxLnG7kZDW7sCzPEh5gNbrwy0n7NC9x2u-WvoKGrzZrUO-Tz--Yx7LN3LV_pQ7GebSykDaBO3nCoqBOamON4953alr9_4AFXSsH7_yRxPhRgEwc6fQ7PRtEx_zzQ-gAehf4QngzJJO9fwOoi7LYkTZMqn--u2Ra3TCmbtkMl76l4M92Dy0lWzR1T_Da_ZheR0RHr_iVcna6-fTkrxiQJhSPNtqFt1PkovCDEhmBFGYUKtkX0baM9WqxDGyOWBNNYQn9lfUQlg-wicgpwV7-CvX7bhzeQe-waxQeBVSS5qtNd6WylS-mldBxIMINPE5KMGyOIcyKL72aIfYyGUGomlGbwcYa-GSJn_AXuhPE9w3C86_SAcGRGrBjBapJraxdqLaJWVtKssjRO2nNsV7kMjiZqmXER7kxdtqjpD6LK4P3cTMuHz0RsH4geBrVuWnZPJpjXA5XnntS0d5EGrzIYJuI_h8GVqfz2f194B085jf1wBe0I9u5uf4RjEnbuukWa0QvYP1ldrr8ukslgkWxSPwGSS_bo
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VrRBcEG8CBYJETyhsMnYS54AQha22tLuqUCvtzTh-SJVQsjSt0P4pfiPjvFAl6K23PCaRPTMez9gz_gDe5kY5m3uMMCxERDN-FpUW8wg1Gme0SNMWkmWxzOan_OsqXW3B76EWxqdVDjaxNdSm1n6NfMriAgX53zz5uP4ZedQov7s6QGh0anFoN78oZGs-HHwh-e4i7s9OPs-jHlUg0hQKZmR3tHHccGqJtYrHjudWFYimyIRBhcwWzmFMNJmi9ibKOMxTm5YOPWa2ZvTfW7DNWRbjBLb3Zsvjb-OqDsUfKNr6O8yp2xgXos-2p3fT2eqYIlL0KQfZlXmwhQv4l4971WVu57z9-3Cvd1bDT512PYAtWz2E2x185eYRzBa2qcl_ry-bsDnzq3_TFiSq7m7Cii7XQ-ZdSN5xqL2OnYdnviilL_3aPIbTG2HgE5hUdWWfQWiwzHK_9Zg48uRKUcZaJSJOTZpqf3RhAO8GJkndn1nuoTN-yO60ZZTEUjmwNIDdkXrdndXxH7o9z--Rxp-w3T4gHsmeK5L7wEwXTFsmuBO5SkmPFfWTrJwqEx3AziAt2Q_7Rv5V0gDejK9pwPpdGFVZkodEIbLCF0QTzdNOymNLGFlLxkQewPtW7Nd2w98M18-vb81ruDM_WRzJo4Pl4Qu4S1-xLt1tByYX55f2JTlWF-WrXptD-H7TA-gPOqcyTg
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlR3LjtQwzIJFIC6IN4UFigQnVE3rJk165DGj5bGrObDS3KI0D2kl1BntLIf9e-ymLawESNySxm0TO4kfiW2A18rbGBTnCMNWF8Txm6ILqAp06KN3WsohJcvxSXN0Kj5v5GY0uLEvTIoPMRvceGUM-zUv8J2Pi19BQ5ebNal3yOf3zXW4wed9fKULxXq2sZA2gHrwhkNFndDEHMe779S2-P0DV7jSELz_TxLnVQF24ECru3BnFB3zd4nW9-Ba6O_DzZRM8vIBLI_DfkvSNKny-f6MbXGLIWXTNlXynoq76R5cTrJq7pji5_kZu4iMjliXD-F0tfz24agYkyQUjjTbhrZR56PwghAbghVlFCrYFtG3jfZosQ5tjFgSTGMJ_ZX1EZUMsovIKcBd_QgO-m0fnkDusWsUHwRWkeSqTnels5UupZfScSDBDN5OSDJujCDOiSy-mxT7GA2h1EwozeDNDL1LkTP-Avee8T3DcLzr4QHhyIxYMYLVJNfWLtRaRK2spFllaZy059iuchkcTtQy4yLcm7psUdMfRJXBq7mZlg-fidg-ED0Mat207J5MMI8Tleee1LR3kQavMkgT8Z_D4MpUfvq_L7yEW-uPK_P108mXZ3CbM9qn22iHcHBx_iM8J7nnonsxTO6fKhX15w
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Mesoporous+silica%2Forganosilica+nanoparticles+for+cancer+immunotherapy&rft.jtitle=Exploration+%28Beijing%2C+China%29&rft.au=Theivendran%2C+Shevanuja&rft.au=Lazarev%2C+Sergei&rft.au=Yu%2C+Chengzhong&rft.date=2023-06-01&rft.issn=2766-2098&rft.eissn=2766-2098&rft.volume=3&rft.issue=3&rft_id=info:doi/10.1002%2FEXP.20220086&rft.externalDBID=n%2Fa&rft.externalDocID=10_1002_EXP_20220086
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2766-8509&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2766-8509&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2766-8509&client=summon